Dexcom

EDINBURGH, Scotland–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning platform …

Our Digital Marketing Manager has had diabetes for 13+ years. How long has it been since your diagnosis? Tell us in the …

In this week’s issue of The Savvy Diabetic:  FDA Approves Kristy – Biosimilar to Novolog Dexcom Responds to Sensor Failures & More ‘Ozempic Teeth’ GLP-1 Side Effect Innovations in Preventing/Treating …

A continuous glucose monitor (CGM) is a monitoring device used by people with diabetes. They apply them directly to the skin and monitor blood sugar readings in real time. Dexcom’s …

New data shows long-term use of an AID system powered by Dexcom CGM can safely maintain improvements in glycaemic outcomes for up to two years1. Real-world evidence demonstrates reduction in …